SCHEMBL23166446

SCHEMBL23166446

O=C(NO)c1cnc(CN2C(=O)COc3ccccc32)c(F)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHRM1 P11229 1/20 0.49
▸ ALDH1A1 P00352 4/20 0.46
▸ GAA P10253 2/20 0.46
▸ KDM4E B2RXH2 2/20 0.46
▸ MAPT P10636 1/20 0.46
▸ CBX7 O95931 2/20 0.44
▸ CDYL2 Q8N8U2 2/20 0.44
▸ CDYL Q9Y232 2/20 0.44
▸ CDY1; CDY1B Q9Y6F8 2/20 0.44
▸ TSHR P16473 3/20 0.44
▸ USP2 O75604 1/20 0.44
▸ GRM5 P41594 1/20 0.43
▸ HDAC1 Q13547 1/20 0.43
▸ HDAC8 Q9BY41 1/20 0.43
▸ HDAC6 Q9UBN7 1/20 0.43
▸ HDAC5 Q9UQL6 1/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ POLB P06746 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29779602 1.00 CHRM1 (0.49) CHRM1ALDH1A1GAAKDM4EMAPT
SCHEMBL25138325 0.81 HDAC6 (0.54) ALDH1A1MAPTTSHRGRM5HDAC1
SCHEMBL23202576 0.77 HDAC6 (0.43) CHRM1HDAC1HDAC8HDAC6HDAC5
SCHEMBL18581560 0.74 KDM4E (0.50) CHRM1ALDH1A1KDM4EMAPTTSHR
SCHEMBL29790608 0.71 BRD4 (0.55) ALDH1A1KDM4EMAPTCBX7CDYL2
SCHEMBL18581748 0.71 BRD4 (0.55) ALDH1A1KDM4EMAPTCBX7CDYL2
SCHEMBL18581471 0.71 CBX7 (0.46) ALDH1A1KDM4EMAPTCBX7CDYL2
SCHEMBL29790714 0.71 CBX7 (0.46) ALDH1A1KDM4EMAPTCBX7CDYL2
SCHEMBL23201987 0.71 HDAC6 (0.45) ALDH1A1HDAC1HDAC8HDAC6HDAC5
SCHEMBL18581373 0.71 ALDH1A1 (0.58) ALDH1A1KDM4EMAPTHDAC1HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230123856-A1 5-FLUORONICOTINAMIDE DERIVATIVES AND USES THEREOF TENAYA THERAPEUTICS, INC. (US) 2023-04-20 — — US disclosed
US-20230123856-A1 5-FLUORONICOTINAMIDE DERIVATIVES AND USES THEREOF TENAYA THERAPEUTICS, INC. (US) 2023-04-20 — — US disclosed
EP-4037670-A1 5-FLUORONICOTINAMIDE DERIVATIVES AND USES THEREOF Tenaya Therapeutics, Inc. (US) 2022-08-10 — — EP disclosed
WO-2021067859-A1 5-FLUORONICOTINAMIDE DERIVATIVES AND USES THEREOF TENAYA THERAPEUTICS, INC. (US) 2021-04-08 — — WO disclosed
WO-2021067859-A1 5-FLUORONICOTINAMIDE DERIVATIVES AND USES THEREOF TENAYA THERAPEUTICS, INC. (US) 2021-04-08 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230123856-A1 5-FLUORONICOTINAMIDE DERIVATIVES AND USES THEREOF SLC28A1, SLC5A1, SLC9A5 CHRM1 1887/4885ALDH1A1 206/4885GAA 977/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback